Literature DB >> 8183434

GABAA receptor-mediated excitation of nociceptive afferents in the rat isolated spinal cord-tail preparation.

B Ault1, L M Hildebrand.   

Abstract

Algogens such as capsaicin, bradykinin, acetylcholine, 5-hydroxytryptamine and potassium ions applied to exposed tail skin of the rat isolated spinal cord-tail preparation evoke a ventral root response consisting of depolarization and spiking activity. L-glutamate and kainate also evoke similar reflexes. All these compounds evoke depolarization of afferent axons or dorsal root ganglion cells. Since GABA depolarizes unmyelinated afferent fibers, the ability of GABA receptor agonists to activate cutaneous nociceptive afferents has been examined. GABA superfused over exposed tail skin evoked a ventral root reflex essentially identical to that produced by capsaicin (3 microM). The EC50 was 27 microM. Muscimol, 3-aminopropane sulphonate, isoguvacine and beta-alanine had effects comparable to GABA, with EC50 values of 9.6, 26, 56 and 870 microM respectively. Baclofen (100 microM) or glycine (10 mM) had no effect. Bicuculline applied to the tail competitively antagonized GABA (Schild slope = -1.03) with a pA2 of 5.8. Spinal application of 1 microM morphine blocked the actions of GABA and capsaicin. These data indicate that GABAA receptors can depolarize and excite nociceptive afferents. GABA could be involved in nociception by contributing to firing of C-fibres, or by analogy to presynaptic inhibition in the spinal cord, may act to decrease neuropeptide transmitter release in cutaneous tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183434     DOI: 10.1016/0028-3908(94)90104-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Molecular and functional expression of cation-chloride cotransporters in dorsal root ganglion neurons during postnatal maturation.

Authors:  Shihong Mao; Tomás Garzon-Muvdi; Mauricio Di Fulvio; Yanfang Chen; Eric Delpire; Francisco J Alvarez; Francisco J Alvarez-Leefmans
Journal:  J Neurophysiol       Date:  2012-03-28       Impact factor: 2.714

2.  Some new insights into the molecular mechanisms of pain perception.

Authors:  David A Brown; Gayle M Passmore
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

3.  Calmodulin contributes to gating control in olfactory calcium-activated chloride channels.

Authors:  Hiroshi Kaneko; Frank Möhrlen; Stephan Frings
Journal:  J Gen Physiol       Date:  2006-06       Impact factor: 4.086

4.  The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors.

Authors:  Michael J M Fischer; Andreas Leffler; Florian Niedermirtl; Katrin Kistner; Mirjam Eberhardt; Peter W Reeh; Carla Nau
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

5.  Na+,K+,2Cl- cotransport and intracellular chloride regulation in rat primary sensory neurons: thermodynamic and kinetic aspects.

Authors:  Héctor I Rocha-González; Shihong Mao; Francisco J Alvarez-Leefmans
Journal:  J Neurophysiol       Date:  2008-04-02       Impact factor: 2.714

6.  Propofol-induced pain sensation involves multiple mechanisms in sensory neurons.

Authors:  Rei Nishimoto; Makiko Kashio; Makoto Tominaga
Journal:  Pflugers Arch       Date:  2014-10-10       Impact factor: 3.657

7.  Anoctamin 1 mediates thermal pain as a heat sensor.

Authors:  Hawon Cho; Uhtaek Oh
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

8.  Eugenol inhibits the GABAA current in trigeminal ganglion neurons.

Authors:  Sang Hoon Lee; Jee Youn Moon; Sung Jun Jung; Jin Gu Kang; Seung Pyo Choi; Jun Ho Jang
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

9.  Modulation of chloride homeostasis by inflammatory mediators in dorsal root ganglion neurons.

Authors:  Katharina Funk; Anne Woitecki; Christina Franjic-Würtz; Thomas Gensch; Frank Möhrlen; Stephan Frings
Journal:  Mol Pain       Date:  2008-08-12       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.